Skip to main content

Table 1 Clinical and pathological characteristics for patients with a duodenal GIST

From: Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum

Variable

All patients (n= 48)

Age

 

  Median

53 years

  Range

27 to 89 years

Gender

 

  Male

28 (58.3%)

  Female

20 (41.7%)

Presentation

 

  Bleeding

29 (60.4%)

  Incidental finding

8 (16.7%)

  Abdominal discomfort

7 (14.6%)

  Abdominal pain

3 (6.3%)

  Jaundice

1 (2%)

Tumor size

 

  Median

4.7 cm

  Range

2.0 to 15.0 cm

Mitotic count

 

  ≤5 mitosis/50 HPF

36 (75.0%)

  6 to 10 mitosis/50 HPF

4 (8.3%)

  mitosis HPF

8 (16.7%)

NIH risk classification

 

  Low risk

28 (58.3%)

  Intermediate risk

11 (22.9%)

  High risk

9 (18.8%)

Site

 

  D1

11 (22.9%)

  D2

17 (35.4%)

  D3

6 (12.5%)

  D4

2 (4.2%)

  D1/D2

8 (16.7%)

  D2/D3

4 (8.3%)

CD117

 

  Positive

47 (97.9%)

  Negative

1 (2.1%)

CD34

 

  Positive

32 (66.7%)

  Negative

16 (33.3%)

Desmin

 

  Positive

6 (12.5%)

  Negative

42 (87.5%)

S-100

 

  Positive

5 (10.4%)

  Negative

43 (89.6%)

  1. D1, first part of the duodenum; D2, second part of the duodenum; D3, third part of the duodenum; D4, fourth part of the duodenum; NIH, National Institutes of Health.